The use of inhaled anticholinergics in chronic obstructive pulmonary disease. Is there cause for concern of cardiovascular safety?

The use of inhaled anticholinergics in chronic obstructive pulmonary disease. Is there cause for concern of cardiovascular safety?

R. McIvor

DOI: 10.20452/pamw.813

Published online: November 01, 2009
CC BY-NC-SA 4.0

Full-text article available only as a pdf file for download

Download PDF

Most cited

Lippi G, Wong J, Henry B

Pol Arch Intern Med. 2020, Vol. 130, No. 4: 304–309; DOI: 10.20452/pamw.15272

Staszel T, Zapała B, Polus A, Sadakierska‑Chudy A, Kieć‑Wilk B, Stępień E, Wybrańska I, Chojnacka M, Dembińska‑Kieć A

Pol Arch Intern Med. 2011, Vol. 121, No. 10: 361–367; DOI: 10.20452/pamw.1093

Kasińska M, Drzewoski J

Pol Arch Intern Med. 2015, Vol. 125, No. 11: 803–813; DOI: 10.20452/pamw.3156

Chou R

Pol Arch Intern Med. 2009, Vol. 119, No. 7-8: 469–477; DOI: 10.20452/pamw.741

Edrees H, Paine L, Feroli E, Wu A

Pol Arch Intern Med. 2011, Vol. 121, No. 4: 101–108; DOI: 10.20452/pamw.1033

Lippi G, Sanchis-Gomar F, Henry B

Pol Arch Intern Med. 2023, Vol. 133, No. 4: 16402; DOI: 10.20452/pamw.16402

Yao Q, Wang P, Wang X, Qie G, Meng M, Tong X, Bai X, Ding M, Liu W, Liu K, Chu Y

Pol Arch Intern Med. 2020, Vol. 130, No. 5: 390–399; DOI: 10.20452/pamw.15312